Annual clinical updates in hematological malignancies: A continuing medical education series. Hodgkin lymphoma: 2011 update on diagnosis, risk-stratification, and management

Medicine & Life Sciences

• Continuing Medical Education 100%
• Risk Management 82%
• Hodgkin Disease 77%
• Hematologic Neoplasms 76%
• Drug Therapy 22%
• Stem Cells 13%
• Lymphocyte Depletion 13%
• Radiotherapy 13%
• Transplants 11%
• Recurrence 10%
• Sclerosis 10%
• Combination Drug Therapy 9%
• Standard of Care 9%
• Allografts 8%
• Lymphoma 7%
• Therapeutics 7%
• Histology 7%
• B-Lymphocytes 7%
• Lymphocytes 6%
• Clinical Trials 6%
• Neoplasms 3%